CD44 and cholangiocarcinoma: This counterintuitive role, where loss of expression is detrimental, highlights the context-dependent nature of CD44 in cancer biology and lends external support to our hypothesis that the CD44s-v5-v6 Null phenotype in CCA may represent a distinct and highly aggressive disease subtype.